The purpose of the Administrative Core is to ensure the efficient execution of all aspects of the Program Aims and to maintain quality control within the Program. One of the major aspirations of the Program and the Principal Investigator is to create an ethos for maximal integration of the components to better serve this PPG, the field of PDT, cancer research, and the community at large. To this end, she has brought together a team of new and existing scientists and physicians who are already collaborating enthusiastically. A change in this cycle is the addition of Dr. Pogue to this Core, which wjll be key for the two new additional functions, and the addition of Dr. Verma as the Program Manager. In addition to the two broad functions of Scientific and Administrative coordination, the renewal application adds the goals of career development, intellectual property (IP) development, and data sharing to this Core. The scientific coordination will be maintained through a variety of mechanisms that will include regular intra- and inter- Project/Core meetings. Two formal steering groups provide oversight of the Program: an Executive Steering Committee (ESC) and an external Scientific Advisory Board (SAB). The ESC consists of the individual Project Leaders and Core Directors and co- Directors;each member has expertise in a different aspect of the Program. This Core will: a) perform monthly reviews and identify obstacles;b) coordinate two ESC meetings per year, with selected consultants and key personnel in Boston;c) organize an SAB and a follow-up action plan meeting of the ESC;and lastly d) achieve additional scientific enhancement via a mini-symposium of one speaker/year on topics within the larger perspective of cancer biology relevant to the Program, but not directly in the area of PDT. As PDT does not clearly fit into an existing medical paradigm, special care will need to be taken to ensure that where appropriate, technologies get IP protection and find optimal development partners consistent with one of the goals of the NIH Roadmap for private-public partnerships. The career advancement goal captures the Core Leaders'strengths at their respective institutions and will intentionally encourage and recruit promising young investigators to scientific education and PDT, and ultimately help with placement of appropriate individuals at high caliber scientific institutions. For administrative coordination, the Core will a) track funds for each Project, b) coordinate and compile reports to the NIH, c) maintain records for major equipment purchases, repairs, and service contracts pertinent to this Program, and d) track travel and make the most cost-effective arrangements. The Core will also be responsible for data sharing via its website, part of which will be publicly accessible and interactive. The scientific and administrative coordination described above is crucial to ensure efficient execution of the Program, enabling the many different components to perform optimally. Potential benefits to public health: this Core ensures the maximal integration and impact of NCI resources to develop new treatments for three cancers that are a burden to society in several different ways.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA084203-10
Application #
8403912
Study Section
Special Emphasis Panel (ZCA1-GRB-P)
Project Start
Project End
2014-12-31
Budget Start
2013-01-01
Budget End
2013-12-31
Support Year
10
Fiscal Year
2013
Total Cost
$104,968
Indirect Cost
$44,670
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Pereira, S P; Goodchild, G; Webster, G J M (2018) The endoscopist and malignant and non-malignant biliary obstruction. Biochim Biophys Acta Mol Basis Dis 1864:1478-1483
Broekgaarden, Mans; Rizvi, Imran; Bulin, Anne-Laure et al. (2018) Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids. Oncotarget 9:13009-13022
Huang, Huang-Chiao; Rizvi, Imran; Liu, Joyce et al. (2018) Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery. Cancer Res 78:558-571
Huang, Huang-Chiao; Pigula, Michael; Fang, Yanyan et al. (2018) Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects. Small :e1800236
Wang, Hexuan; Mislati, Reem; Ahmed, Rifat et al. (2018) Elastography can map the local inverse relationship between shear modulus and drug delivery within the pancreatic ductal adenocarcinoma microenvironment. Clin Cancer Res :
Obaid, Girgis; Jin, Wendong; Bano, Shazia et al. (2018) Nanolipid Formulations of Benzoporphyrin Derivative: Exploring the Dependence of Nanoconstruct Photophysics and Photochemistry on Their Therapeutic Index in Ovarian Cancer Cells. Photochem Photobiol :
Marra, Kayla; LaRochelle, Ethan P; Chapman, M Shane et al. (2018) Comparison of Blue and White Lamp Light with Sunlight for Daylight-Mediated, 5-ALA Photodynamic Therapy, in vivo. Photochem Photobiol 94:1049-1057
Pereira, Stephen P; Jitlal, Mark; Duggan, Marian et al. (2018) PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer. ESMO Open 3:e000379
Maytin, Edward V; Kaw, Urvashi; Ilyas, Muneeb et al. (2018) Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study. Photodiagnosis Photodyn Ther 22:7-13
de Souza, Ana Luiza Ribeiro; LaRochelle, Ethan; Marra, Kayla et al. (2017) Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ. Photodiagnosis Photodyn Ther 20:227-233

Showing the most recent 10 out of 173 publications